Reactions Weekly

, Volume 1190, Issue 1, pp 2–2 | Cite as

The perception that gemfibrozil has a less favourable safety profile than fenofibrate may no longer be clinically relevant

Clinical study


Public Health Adverse Event Safety Profile Fenofibrate Gemfibrozil 


  1. 1.
    Holoshitz N, Alsheikh-Ali AA, Karas RH.Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin use. American Journal of Cardiology 101: 95-97, No. 1, 1 Jan 2008Google Scholar

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations